(CR 09) Dose by Dose: Making Eptinezumab Possible Through Desensitization

Presenting Author(s)

AV

Aimen Vanood, MD

Headache Fellow
Mayo Clinic, United States
VH

Victoria Hough, BS

Mayo Clinic Alix School of Medicine, United States
AI

Aimee Itaaehau, PharmD

Mayo Clinic, United States
AW

Alex Wonnaparhown, MD

Mayo Clinic, United States
Juliana VanderPluym, MD

Associate Professor of Neurology
Mayo Clinic Arizona
Scottsdale, AZ, United States
Amaal J. J. Starling, MD

Associate Professor of Neurology
Mayo Clinic Arizona
Scottsdale, Arizona, United States
AG

Alexei Gonzalez-Estrada, MD

Mayo Clinic, United States